Capstone received an extension from Nasdaq and now has until January 4, 2027 to regain the $1.00 minimum bid price for continued listing.
Key Highlights:
- Nasdaq notified Capstone that its stock closed below the $1.00 minimum bid price for 30 consecutive business days.
- Initial cure period expired July 6, 2026; Nasdaq granted an additional 180-day extension through Jan. 4, 2027.
- If compliance is not regained by Jan. 4, 2027, Nasdaq will notify Capstone of delisting and the company may appeal to a Hearings Panel.
- Capstone will monitor its closing bid and may consider options to regain compliance, but outcome is uncertain.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.